Astellas Pharma Global Development, Inc.
213
20
34
139
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 65/100
15.5%
33 terminated/withdrawn out of 213 trials
80.8%
-5.7% vs industry average
17%
37 trials in Phase 3/4
42%
59 of 139 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (213)
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
Role: lead
A Study to Find Out if Enfortumab Vedotin Given With Pembrolizumab Helps People With Muscle-invasive Bladder Cancer Keep Their Bladder
Role: lead
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
Role: lead
Zimura Compared to Sham in Patients With Autosomal Recessive Stargardt Disease (STGD1)
Role: lead
Avacincaptad Pegol Open-Label Extension for Patients With Geographic Atrophy
Role: lead
A Study to Learn How Stargardt-type Eye Conditions Progress in Children and Adults
Role: lead
A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study
Role: lead
A Study to Evaluate Enfortumab Vedotin in Subjects With Locally Advanced or Metastatic Malignant Solid Tumors (EV-202)
Role: lead
A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Atrophy
Role: lead
A Study of ASP1570 Taken by Itself, or ASP1570 Taken Together With Either Pembrolizumab, Standard Therapies, or Both, in Adults With Solid Tumors
Role: lead
A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer
Role: lead
A Study of ASP2998 Given by Itself and Given With Standard Therapies in People With Solid Tumors
Role: lead
A Study to Evaluate the Effects of ASP5502 in Healthy Adults and Adults With Primary Sjögren's Syndrome
Role: lead
A Natural History Study of Angelman Syndrome
Role: collaborator
A Study of Enfortumab Vedotin Alone or With Other Therapies for Treatment of Urothelial Cancer
Role: lead
A Study to Confirm if Fezolinetant Helps Reduce Hot Flashes in Chinese Women Going Through Menopause
Role: lead
A Study of ASP1002 in Adults for Treatment of Solid Tumors
Role: lead
A Study of ASP2138 Given Before Surgery, Then Chemotherapy After Surgery, in People With Pancreatic Ductal Cancer
Role: lead
A Study of Zolbetuximab (IMAB362) in Adults With Pancreatic Cancer
Role: lead
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
Role: lead